Source: Clinical Cancer Research. Conference titles: AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics. Unidade: FCF
Subjects: ANTINEOPLÁSICOS (ESTUDO CLÍNICO), NEOPLASIAS (TERAPIA), QUIMIOTERAPIA, QUIMIOTERÁPICOS, LIPÍDEOS (FISIOLOGIA), FARMACOLOGIA
ABNT
RODRIGUES, Daniella Goulart et al. Use of a cholesterol-rich emulsion that to low-density lipoprotein receptors as carrier for paclitaxel. Clinical Cancer Research. Birmingham: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 07 nov. 2024. , 2001APA
Rodrigues, D. G., Covollan, C. C., Coradi, S., Barboza, R., & Maranhão, R. C. (2001). Use of a cholesterol-rich emulsion that to low-density lipoprotein receptors as carrier for paclitaxel. Clinical Cancer Research. Birmingham: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Rodrigues DG, Covollan CC, Coradi S, Barboza R, Maranhão RC. Use of a cholesterol-rich emulsion that to low-density lipoprotein receptors as carrier for paclitaxel. Clinical Cancer Research. 2001 ; 7( 11): 3675s res. 111.[citado 2024 nov. 07 ]Vancouver
Rodrigues DG, Covollan CC, Coradi S, Barboza R, Maranhão RC. Use of a cholesterol-rich emulsion that to low-density lipoprotein receptors as carrier for paclitaxel. Clinical Cancer Research. 2001 ; 7( 11): 3675s res. 111.[citado 2024 nov. 07 ]